HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuehua Liu Selected Research

Fox-Fordyce Disease

1/2020Rapid remission with calcipotriol betamethasone in refractory Fox-Fordyce disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuehua Liu Research Topics

Disease

9Neoplasms (Cancer)
03/2021 - 01/2009
6Mycosis Fungoides
01/2022 - 08/2014
4Hypoxia (Hypoxemia)
03/2021 - 03/2014
3Bacterial Infections (Bacterial Infection)
01/2022 - 02/2017
3Obstructive Sleep Apnea
03/2021 - 05/2008
2Infections
01/2022 - 05/2002
2Malocclusion (Crossbite)
01/2022 - 01/2017
2Ichthyosis (Xeroderma)
01/2022 - 01/2021
2Leiomyoma (Uterine Fibroids)
03/2021 - 02/2020
2Bone Resorption
07/2019 - 02/2017
2Inflammation (Inflammations)
07/2019 - 02/2017
2Stomach Neoplasms (Stomach Cancer)
01/2017 - 02/2015
2Brain Injuries (Brain Injury)
01/2017 - 01/2017
1Skin Diseases (Skin Disease)
01/2022
1Nonsyndromic Deafness
01/2022
1Hearing Loss (Hearing Impairment)
01/2022
1Erythrokeratodermia Variabilis
01/2022
1Hemangiopericytoma
03/2021
1Vulvar Lichen Sclerosus
03/2021
1Menorrhagia
03/2021
1Perivascular Epithelioid Cell Neoplasms
03/2021
1Autoimmune Diseases (Autoimmune Disease)
01/2021
1Hyperpigmentation
01/2021
1POEMS Syndrome (Syndrome, POEMS)
01/2021
1Mycoses (Diseases, Fungus)
01/2021
1Vitiligo
01/2021
1Skin Manifestations
01/2021
1Type 2 Diabetes Mellitus (MODY)
01/2021
1Paraproteinemias (Monoclonal Gammopathy)
01/2021
1Iron Deficiencies
03/2020
1Hereditary leiomyomatosis and renal cell cancer
02/2020
1Spinal Cord Injuries (Spinal Cord Injury)
01/2020
1Wounds and Injuries (Trauma)
01/2020
1Nasopharyngeal Carcinoma
01/2020
1Fox-Fordyce Disease
01/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2019
1Colorectal Neoplasms (Colorectal Cancer)
08/2019
1Disease Progression
07/2019
1Female Genital Neoplasms
01/2019
1Choriocarcinoma
01/2019
1Keratoacanthoma
01/2018
1Lichen Planus (Lichen Ruber Planus)
01/2018
1Oral Lichen Planus
01/2018
1Sezary Syndrome (Sezary Erythroderma)
04/2017

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
01/2022 - 11/2017
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2019
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2020 - 02/2017
3CytokinesIBA
01/2020 - 02/2017
2Fumarate Hydratase (Fumarase)IBA
03/2021 - 02/2020
2Interleukin-6 (Interleukin 6)IBA
07/2019 - 02/2017
2Estrogens (Estrogen)FDA Link
11/2017 - 03/2014
2ResveratrolIBA
11/2017 - 03/2014
2LipidsIBA
07/2017 - 09/2015
1Pharmaceutical PreparationsIBA
01/2022
1human GJB3 proteinIBA
01/2022
1ConnexinsIBA
01/2022
11-phenyl-3,3-dimethyltriazene (PDT)IBA
03/2021
1AcidsIBA
03/2021
1MyogeninIBA
03/2021
1Cathepsin KIBA
03/2021
1Interferon Type IIBA
01/2021
1Tacrolimus (Prograf)FDA LinkGeneric
01/2021
1Arachidonic Acid (Vitamin F)IBA
01/2021
1Simvastatin (Zocor)FDA LinkGeneric
01/2021
1Bile Acids and Salts (Bile Acids)IBA
01/2021
1Lenalidomide (CC 5013)FDA Link
01/2021
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021
1AlbuminsIBA
10/2020
1Antineoplastic Agents (Antineoplastics)IBA
10/2020
1LigandsIBA
10/2020
1protoporphyrin IXIBA
03/2020
1HematoporphyrinsIBA
03/2020
1calcipotriene (calcipotriol)FDA LinkGeneric
01/2020
1Betamethasone (Celestone)FDA Link
01/2020
1MicroRNAs (MicroRNA)IBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
10/2019
1ParaffinIBA
10/2019
1RNA (Ribonucleic Acid)IBA
08/2019
1Small Nucleolar RNA (snoRNA)IBA
08/2019
1Long Noncoding RNAIBA
08/2019
1Interleukin-17 (Interleukin 17)IBA
07/2019
1InterleukinsIBA
07/2019
1Interleukin-12 (IL 12)IBA
07/2019
1Toll-Like Receptors (Toll-Like Receptor)IBA
07/2019
1RetinoidsIBA
01/2018
1Messenger RNA (mRNA)IBA
11/2017
1SB 203580IBA
11/2017
1Radiation-Sensitizing AgentsIBA
06/2017
1NivolumabIBA
04/2017

Therapy/Procedure

15Therapeutics
01/2022 - 01/2013
4Photochemotherapy (Photodynamic Therapy)
03/2021 - 08/2014
3Radiotherapy
06/2017 - 01/2009
3Drug Therapy (Chemotherapy)
03/2017 - 01/2009
2Hysterectomy
03/2021 - 02/2020
1Uterine Myomectomy
02/2020
1Transplantation
01/2020
1Continuous Positive Airway Pressure
11/2019
1Tooth Extraction (Tooth Extractions)
04/2019
1Immunotherapy
01/2019